Skip to main content
SpringerLink
Log in

Stereotactic Body Radiation Therapy for Liver Metastases: Background and Clinical Evidence

  • Chapter
  • First Online:
Radiation Therapy for Gastrointestinal Cancers

  • 1172 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Grover A, Alexander Jr HR. The past decade of experience with isolated hepatic perfusion. Oncologist. 2004;9:653–64.

    Article  PubMed  Google Scholar 

  2. Bozzetti F, Doci R, Bignami P, et al. Patterns of failure following surgical resection of colorectal cancer liver metastases: rationale for a multimodal approach. Recent Results Cancer Res. 1988;110:164–7.

    Article  CAS  PubMed  Google Scholar 

  3. Hellman S, Weichselbaum RR. Oligometastases. J Clin Oncol. 1995;13:8–10.

    CAS  PubMed  Google Scholar 

  4. Weichselbaum RR, Hellman S. Oligometastases revisited. Nat Rev Clin Oncol. 2011;8:378–82.

    CAS  PubMed  Google Scholar 

  5. Zuckerman DS, Clark JW. Systemic therapy for metastatic colorectal cancer. Cancer. 2008;112:1879–91.

    Article  CAS  PubMed  Google Scholar 

  6. Crane CH, Koay EJ. Solutions that enable ablative radiotherapy for large liver tumors: fractionated dose painting, simultaneous integrated protection, motion management, and computed tomography image guidance. Cancer. 2016;122:1974–86.

    Google Scholar 

  7. Weiss L, Grundmann E, Torhorst J, et al. Haematogenous metastatic patterns in colonic carcinoma: an analysis of 1541 necropsies. J Pathol. 1986;150:195–203.

    Article  CAS  PubMed  Google Scholar 

  8. Wagner JS, Adson MA, Van Heerden JA, et al. The natural history of hepatic metastases from colorectal cancer. A comparison with resective treatment. Ann Surg. 1984;199:502–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Rosen CB, Nagorney DM, Taswell HF, et al. Perioperative blood transfusion and determinants of survival after liver resection for metastatic colorectal carcinoma. Ann Surg. 1992;216:493–504. discussion 504-495.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Hughes KS, Simon R, Songhorabodi S, et al. Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of patterns of recurrence. Surgery. 1986;100:278–84.

    CAS  PubMed  Google Scholar 

  11. Rusthoven CG, Lauro CF, Kavanagh BD, Schefter TE. Stereotactic body radiation therapy (SBRT) for liver metastases: a clinical review. In Seminars in Colon and Rectal Surgery. Elsevier. 2014; 48–52.

    Google Scholar 

  12. Small R, Lubezky N, Ben-Haim M. Current controversies in the surgical management of colorectal cancer metastases to the liver. Isr Med Assoc J. 2007;9:742–7.

    PubMed  Google Scholar 

  13. Kemeny N. Management of liver metastases from colorectal cancer. Oncology (Williston Park). 2006; 20: 1161–1176, 1179; discussion 1179–1180, 1185–1166.

    Google Scholar 

  14. Chu KF, Dupuy DE. Thermal ablation of tumours: biological mechanisms and advances in therapy. Nat Rev Cancer. 2014;14:199–208.

    Article  CAS  PubMed  Google Scholar 

  15. Dou JP, Liang P, Yu J. Microwave ablation for liver tumors. NY: Abdom Radiol; 2016.

    Google Scholar 

  16. Davalos RV, Mir IL, Rubinsky B. Tissue ablation with irreversible electroporation. Ann Biomed Eng. 2005;33:223–31.

    Article  CAS  PubMed  Google Scholar 

  17. Seong J, Keum KC, Han KH, et al. Combined transcatheter arterial chemoembolization and local radiotherapy of unresectable hepatocellular carcinoma. Int J Radiat Oncol Biol Phys. 1999;43:393–7.

    Article  CAS  PubMed  Google Scholar 

  18. Kemeny NE, Chou JF, Boucher TM, et al. Updated long-term survival for patients with metastatic colorectal cancer treated with liver resection followed by hepatic arterial infusion and systemic chemotherapy. J Surg Oncol. 2016;113:477–84.

    Article  PubMed  Google Scholar 

  19. Allen-Mersh TG, Earlam S, Fordy C, et al. Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases. Lancet. 1994;344:1255–60.

    Article  CAS  PubMed  Google Scholar 

  20. Rougier P, Laplanche A, Huguier M, et al. Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial. J Clin Oncol. 1992;10:1112–8.

    CAS  PubMed  Google Scholar 

  21. Pan CC, Kavanagh BD, Dawson LA, et al. Radiation-associated liver injury. Int J Radiat Oncol Biol Phys. 2010;76:S94–100.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Lawrence TS, Robertson JM, Anscher MS, et al. Hepatic toxicity resulting from cancer treatment. Int J Radiat Oncol Biol Phys. 1995;31:1237–48.

    Article  CAS  PubMed  Google Scholar 

  23. Hawkins MA, Dawson LA. Radiation therapy for hepatocellular carcinoma: from palliation to cure. Cancer. 2006;106:1653–63.

    Article  PubMed  Google Scholar 

  24. Reed Jr GB, Cox Jr AJ. The human liver after radiation injury. A form of veno-occlusive disease. Am J Pathol. 1966;48:597–611.

    PubMed  PubMed Central  Google Scholar 

  25. Du SS, Qiang M, Zeng ZC, et al. Radiation-induced liver fibrosis is mitigated by gene therapy inhibiting transforming growth factor-beta signaling in the rat. Int J Radiat Oncol Biol Phys. 2010;78:1513–23.

    Article  CAS  PubMed  Google Scholar 

  26. Ingold JA, Reed GB, Kaplan HS, Bagshaw MA. Radiation hepatitis. Am J Roentgenol Radium Therapy, Nucl Med. 1965;93:200–8.

    CAS  Google Scholar 

  27. Austin-Seymour MM, Chen GT, Castro JR, et al. Dose volume histogram analysis of liver radiation tolerance. Int J Radiat Oncol Biol Phys. 1986;12:31–5.

    Article  CAS  PubMed  Google Scholar 

  28. Dawson LA, McGinn CJ, Normolle D, et al. Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies. J Clin Oncol. 2000;18:2210–8.

    CAS  PubMed  Google Scholar 

  29. Robertson JM, Lawrence TS, Walker S, et al. The treatment of colorectal liver metastases with conformal radiation therapy and regional chemotherapy. Int J Radiat Oncol Biol Phys. 1995;32:445–50.

    Article  CAS  PubMed  Google Scholar 

  30. Dawson LA, Normolle D, Balter JM, et al. Analysis of radiation-induced liver disease using the Lyman NTCP model. Int J Radiat Oncol Biol Phys. 2002;53:810–21.

    Article  PubMed  Google Scholar 

  31. Mohiuddin M, Chen E, Ahmad N. Combined liver radiation and chemotherapy for palliation of hepatic metastases from colorectal cancer. J Clin Oncol. 1996;14:722–8.

    CAS  PubMed  Google Scholar 

  32. Chen FH, Chiang CS, Wang CC, et al. Radiotherapy decreases vascular density and causes hypoxia with macrophage aggregation in TRAMP-C1 prostate tumors. Clin Cancer Res. 2009;15:1721–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Kioi M, Vogel H, Schultz G, et al. Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice. J Clin Invest. 2010;120:694–705.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Song CW, Cho LC, Yuan J, et al. Radiobiology of stereotactic body radiation therapy/stereotactic radiosurgery and the linear-quadratic model. Int J Radiat Oncol Biol Phys. 2013;87:18–9.

    Article  PubMed  Google Scholar 

  35. Blomgren H, Lax I, Göranson H, et al. Radiosurgery for tumors in the body: clinical experience using a new method. J Radiosurgery. 1998;1:63–74.

    Article  Google Scholar 

  36. Blomgren H, Lax I, Naslund I, Svanstrom R. Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients. Acta Oncol. 1995;34:861–70.

    Article  CAS  PubMed  Google Scholar 

  37. Wada H, Takai Y, Nemoto K, Yamada S. Univariate analysis of factors correlated with tumor control probability of three-dimensional conformal hypofractionated high-dose radiotherapy for small pulmonary or hepatic tumors. Int J Radiat Oncol Biol Phys. 2004;58:1114–20.

    Article  PubMed  Google Scholar 

  38. Herfarth KK, Debus J, Lohr F, et al. Stereotactic single-dose radiation therapy of liver tumors: results of a phase I/II trial. J Clin Oncol. 2001;19:164–70.

    CAS  PubMed  Google Scholar 

  39. Hoyer M, Roed H, Traberg Hansen A, et al. Phase II study on stereotactic body radiotherapy of colorectal metastases. Acta Oncol. 2006;45:823–30.

    Article  PubMed  Google Scholar 

  40. Mendez Romero A, Wunderink W, Hussain SM, et al. Stereotactic body radiation therapy for primary and metastatic liver tumors: a single institution phase i-ii study. Acta Oncol. 2006;45:831–7.

    Article  PubMed  Google Scholar 

  41. Rusthoven KE, Kavanagh BD, Cardenes H, et al. Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases. J Clin Oncol. 2009;27:1572–8.

    Article  PubMed  Google Scholar 

  42. Lee MT, Kim JJ, Dinniwell R, et al. Phase I study of individualized stereotactic body radiotherapy of liver metastases. J Clin Oncol. 2009;27:1585–91.

    Article  PubMed  Google Scholar 

  43. Ambrosino G, Polistina F, Costantin G, et al. Image-guided robotic stereotactic radiosurgery for unresectable liver metastases: preliminary results. Anticancer Res. 2009;29:3381–4.

    PubMed  Google Scholar 

  44. Goodman KA, Wiegner EA, Maturen KE, et al. Dose-escalation study of single-fraction stereotactic body radiotherapy for liver malignancies. Int J Radiat Oncol Biol Phys. 2010;78:486–93.

    Article  PubMed  Google Scholar 

  45. Rule W, Timmerman R, Tong L, et al. Phase I dose-escalation study of stereotactic body radiotherapy in patients with hepatic metastases. Ann Surg Oncol. 2011;18:1081–7.

    Article  PubMed  Google Scholar 

  46. Scorsetti M, Arcangeli S, Tozzi A, et al. Is stereotactic body radiation therapy an attractive option for unresectable liver metastases? A preliminary report from a phase 2 trial. Int J Radiat Oncol Biol Phys. 2013;86:336–42.

    Article  PubMed  Google Scholar 

  47. Schefter TE, Kavanagh BD. Radiation therapy for liver metastases. Semin Radiat Oncol. 2011;21:264–70.

    Article  PubMed  Google Scholar 

  48. Dawood O, Mahadevan A, Goodman KA. Stereotactic body radiation therapy for liver metastases. Eur J Cancer. 2009;45:2947–59.

    Article  PubMed  Google Scholar 

  49. Schefter TE, Kavanagh BD, Timmerman RD, et al. A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases. Int J Radiat Oncol Biol Phys. 2005;62:1371–8.

    Article  PubMed  Google Scholar 

  50. Chang DT, Swaminath A, Kozak M, et al. Stereotactic body radiotherapy for colorectal liver metastases: a pooled analysis. Cancer. 2011;117:4060–9.

    Article  PubMed  Google Scholar 

  51. Sato M, Uematsu M, Yamamoto F, et al. Feasibility of frameless stereotactic high-dose radiation therapy for primary or metastatic liver cancer. J Radiosurgery. 1998;1:233–8.

    Article  Google Scholar 

  52. Wurm RE, Gum F, Erbel S, et al. Image guided respiratory gated hypofractionated Stereotactic Body Radiation Therapy (H-SBRT) for liver and lung tumors: initial experience. Acta Oncol. 2006;45:881–9.

    Article  CAS  PubMed  Google Scholar 

  53. Katz AW, Carey-Sampson M, Muhs AG, et al. Hypofractionated stereotactic body radiation therapy (SBRT) for limited hepatic metastases. Int J Radiat Oncol Biol Phys. 2007;67:793–8.

    Article  PubMed  Google Scholar 

  54. Katz AW, Winter KA, Dawson LA et al. RTOG 0438: a phase I trial of highly conformal radiation therapy for patients with liver metastases. In J Clin Oncol 30, 2012 (suppl 4; abstr 257). 2012.

    Google Scholar 

  55. Gunven P, Jonas E, Blomgren H, et al. Undetectable late hepatic sequelae after hypofractionated stereotactic radiotherapy for liver tumors. Med Oncol. 2011;28:958–65.

    Article  PubMed  Google Scholar 

  56. Fode MM, Hoyer M. Survival and prognostic factors in 321 patients treated with stereotactic body radiotherapy for oligo-metastases. Radiother Oncol. 2015;114:155–60.

    Article  PubMed  Google Scholar 

  57. Klein J, Dawson LA, Jiang H, et al. Prospective longitudinal assessment of quality of life for liver cancer patients treated with stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys. 2015;93:16–25.

    Article  PubMed  Google Scholar 

  58. Chang JY, Senan S, Paul MA, et al. Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials. Lancet Oncol. 2015;16:630–7.

    Article  PubMed  PubMed Central  Google Scholar 

  59. https://clinicaltrials.gov/ct2/show/NCT01233544. Radiofrequency ablation versus stereotactic radiotherapy in colorectal liver metastases (RAS01). Accessed March 17, 2016.

  60. Chiba T, Tokuuye K, Matsuzaki Y, et al. Proton beam therapy for hepatocellular carcinoma: a retrospective review of 162 patients. Clin Cancer Res. 2005;11:3799–805.

    Article  PubMed  Google Scholar 

  61. Fukumitsu N, Sugahara S, Nakayama H, et al. A prospective study of hypofractionated proton beam therapy for patients with hepatocellular carcinoma. Int J Radiat Oncol Biol Phys. 2009;74:831–6.

    Article  PubMed  Google Scholar 

  62. Matsuzaki Y, Osuga T, Saito Y, et al. A new, effective, and safe therapeutic option using proton irradiation for hepatocellular carcinoma. Gastroenterology. 1994;106:1032–41.

    Article  CAS  PubMed  Google Scholar 

  63. Hong TS, DeLaney TF, Mamon HJ, et al. A prospective feasibility study of respiratory-gated proton beam therapy for liver tumors. Pract Radiat Oncol. 2014;4:316–22.

    Article  PubMed  Google Scholar 

Download references

Conflicts of Interest

The authors have no conflicts of interest to report.

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, University of Colorado Cancer Center, 1665 Aurora Court, Room 1032, Aurora, CO, 80045, USA

    Karyn A. Goodman MD, MS & Arya Amini MD

Authors
  1. Karyn A. Goodman MD, MS
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Arya Amini MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Karyn A. Goodman MD, MS .

Editor information

Editors and Affiliations

  1. Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA

    Theodore Hong

  2. The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

    Prajnan Das

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Goodman, K.A., Amini, A. (2017). Stereotactic Body Radiation Therapy for Liver Metastases: Background and Clinical Evidence. In: Hong, T., Das, P. (eds) Radiation Therapy for Gastrointestinal Cancers. Springer, Cham. https://doi.org/10.1007/978-3-319-43115-4_17

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-43115-4_17

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-43113-0

  • Online ISBN: 978-3-319-43115-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation